Search research articles
Contact Us
Filters
Showing results (551-560 of 643) with videos related to
Page
of 65
Sort By:
Psychiatry Research
|
June 1, 1991
Plasma catecholamines and their metabolites in obsessive-compulsive disorder
C Benkelfat, I N Mefford, C F Masters, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1991
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder
T A Pigott, M T Pato, F L'Heureux, et al.
Biological Psychiatry
|
April 9, 1998
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls
A Broocks, J T Little, A Martin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 1, 1997
Fluoxetine in the treatment of premenstrual dysphoria
T P Su, P J Schmidt, M A Danaceau, et al.
Neuroscience
|
October 29, 2002
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
F S Hall, X F Li, I Sora, et al.
Psychiatry Research
|
April 1, 1982
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls
L J Siever, T W Uhde, E K Silberman, et al.
The American Journal of Psychiatry
|
November 1, 1986
Intravenous nicotine in a patient with Alzheimer's disease
P A Newhouse, T Sunderland, K Thompson, et al.
Archives of General Psychiatry
|
October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results
T A Pigott, M T Pato, S E Bernstein, et al.
Neuroreport
|
February 25, 2003
Altered rapid eye movement sleep timing in serotonin transporter knockout mice
J P Wisor, S W Wurts, F S Hall, et al.
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects
D L Murphy, R M Cohen, L J Siever, et al.
Page
of 65
Search research articles
Search
Showing results (551-560 of 643) with videos related to
Sort By:
Page
of 65
Psychiatry Research
|
June 1, 1991
Plasma catecholamines and their metabolites in obsessive-compulsive disorder
C Benkelfat, I N Mefford, C F Masters, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1991
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder
T A Pigott, M T Pato, F L'Heureux, et al.
Biological Psychiatry
|
April 9, 1998
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls
A Broocks, J T Little, A Martin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 1, 1997
Fluoxetine in the treatment of premenstrual dysphoria
T P Su, P J Schmidt, M A Danaceau, et al.
Neuroscience
|
October 29, 2002
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
F S Hall, X F Li, I Sora, et al.
Psychiatry Research
|
April 1, 1982
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls
L J Siever, T W Uhde, E K Silberman, et al.
The American Journal of Psychiatry
|
November 1, 1986
Intravenous nicotine in a patient with Alzheimer's disease
P A Newhouse, T Sunderland, K Thompson, et al.
Archives of General Psychiatry
|
October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results
T A Pigott, M T Pato, S E Bernstein, et al.
Neuroreport
|
February 25, 2003
Altered rapid eye movement sleep timing in serotonin transporter knockout mice
J P Wisor, S W Wurts, F S Hall, et al.
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects
D L Murphy, R M Cohen, L J Siever, et al.
Page
of 65